Immunovant (IMVT) Stock Price
$21.27 0%
to add to portfolio
AI Score
-
Alternative
0 -
Fundamental
6 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Immunovant, AI stock picks, stock alerts and much more.
IMVT AI Stock Analysis
AI stock analysis for IMVT is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Immunovant (IMVT) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Immunovant (IMVT) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Immunovant (IMVT), currently trading at $21.27, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About IMVT
-
Immunovant, Inc.
-
Symbol
IMVT
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
3.6B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
IMVT Alternative Data
Web Traffic
Immunovant receives an estimated 4749 monthly visitors to immunovant.com.
-
Web Traffic
4749
-
Change from Previous Month
49.4%
-
3 Month Change
60.2%
News Mentions
Immunovant was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Immunovant has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Job Postings
Immunovant currenly has an estimated 10 open job postings, up by 11.1% over the last month.
-
Job Postings
10
-
Daily Change
0%
-
1 Month Change
11.1%
-
3 Month Change
42.9%
LinkedIn Employees
According to LinkedIn, Immunovant has 355 employees, up by 1.7% over the last month.
-
LinkedIn Employees
355
-
Daily Change
0%
-
1 Month Change
1.7%
-
3 Month Change
9.9%
Business Outlook
-
Business Outlook
53
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
IMVT Financials
IMVT Key Metrics
-
Total Revenue
$0
-
Net Income
-$109.1M
-
Earnings per Share
-$0.74
-
Free cash flow
-$88.8M
-
EBITDA
-$115.7M
-
EBITDA Ratio
0
-
Total Assets
$515.7M
IMVT 2-year Revenue & Income
IMVT 2-year Free Cash Flow
IMVT Technicals
IMVT SMA
IMVT RSI
FAQ
What's the current price of Immunovant (IMVT) Stock?
The price of an Immunovant (IMVT) share is $21.27.
What's the market cap of Immunovant?
The current market cap of Immunovant is 3.6B.
Should I buy or sell IMVT?
Immunovant shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Immunovant is better viewed as a hold or accumulate position while waiting for further developments.
Is Immunovant a good investment?
The current analysis of Immunovant's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Immunovant's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Immunovant (IMVT) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Immunovant stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Immunovant (IMVT) that investors often compare it to?
Immunovant (IMVT) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Immunovant's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Immunovant's stock price to be around $20.59 in 2026. Starting from the current price of $21.27, this represents a 3.2% change in price, indicating a neutral outlook for the stock.
How to buy Immunovant (IMVT) Stock?
Immunovant stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Immunovant shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.